Orchard Therapeutics Statistics

Total Valuation

ORTX has a market cap or net worth of $756.82 million. The enterprise value is $679.23 million.

Market Cap	756.82M
Enterprise Value	679.23M

Important Dates

The last earnings date was Monday, March 4, 2024, before market open.

Earnings Date	Mar 4, 2024
Ex-Dividend Date	n/a

Share Statistics

ORTX has 45.32 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	45.32M
Owned by Insiders (%)	12.21%
Owned by Institutions (%)	103.60%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	34.65
Forward PS	15.26
PB Ratio	9.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	31.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.60.

Current Ratio	3.12
Quick Ratio	2.67
Debt / Equity	0.60
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.24

Financial Efficiency

Return on equity (ROE) is -74.90% and return on invested capital (ROIC) is -79.65%.

Return on Equity (ROE)	-74.90%
Return on Assets (ROA)	-33.50%
Return on Capital (ROIC)	-79.65%
Revenue Per Employee	$131,560
Profits Per Employee	-$439,283
Employee Count	166
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	-140,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +165.50% in the last 52 weeks. The beta is 0.55, so ORTX's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+165.50%
50-Day Moving Average	16.33
200-Day Moving Average	9.46
Relative Strength Index (RSI)	85.36
Average Volume (20 Days)	128,841

Short Selling Information

Short Interest	27,197
Short Previous Month	41,001
Short % of Shares Out	0.15%
Short % of Float	n/a
Short Ratio (days to cover)	0.28

Income Statement

In the last 12 months, ORTX had revenue of $21.84 million and -$72.92 million in losses. Loss per share was -$4.00.

Revenue	21.84M
Gross Profit	15.11M
Operating Income	-102.02M
Pretax Income	-73.06M
Net Income	-72.92M
EBITDA	-66.59M
EBIT	-69.26M
Loss Per Share	-$4.00

Full Income Statement

Balance Sheet

The company has $125.41 million in cash and $47.82 million in debt, giving a net cash position of $77.59 million or $1.71 per share.

Cash & Cash Equivalents	125.41M
Total Debt	47.82M
Net Cash	77.59M
Net Cash Per Share	$1.71
Equity (Book Value)	80.26M
Book Value Per Share	1.77
Working Capital	104.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$93.32 million and capital expenditures $6.87 million, giving a free cash flow of -$86.44 million.

Operating Cash Flow	-93.32M
Capital Expenditures	6.87M
Free Cash Flow	-86.44M
FCF Per Share	-$3.79

Full Cash Flow Statement

Margins

Gross margin is 69.17%, with operating and profit margins of -467.13% and -333.90%.

Gross Margin	69.17%
Operating Margin	-467.13%
Pretax Margin	-334.54%
Profit Margin	-333.90%
EBITDA Margin	-304.93%
EBIT Margin	-317.16%
FCF Margin	-395.82%

Dividends & Yields

ORTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.24%
Shareholder Yield	-78.24%
Earnings Yield	-9.64%
FCF Yield	-11.42%

Analyst Forecast

The average price target for ORTX is $21.67, which is 29.76% higher than the current price. The consensus rating is "Buy".

Price Target	$21.67
Price Target Difference	29.76%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	31.76%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 10, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Mar 10, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

ORTX has an Altman Z-Score of -3.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.37
Piotroski F-Score	2